Found 38 Enz. Inhib. hit(s) with all data for entry = 8444 TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.0600nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.0600nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.0600nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.0600nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.0700nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.0800nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.0800nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.130nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.140nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.140nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.140nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.150nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.160nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.180nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.210nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.220nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.220nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.230nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.25nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [241-356](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.270nMT: 2°CAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of N-His-Tb-BIR3(241-356,...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.460nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.480nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.490nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.620nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 0.720nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 1.10nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 1.11nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 1.14nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 1.19nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 1.25nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 1.70nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 1.84nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 2nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 2.11nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 2.21nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 2.43nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 2.44nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase XIAP [124-240](Homo sapiens (Human))
Bristol-Myers Squibb Company
US Patent
Bristol-Myers Squibb Company
US Patent
Affinity DataIC50: 2.68nMT: 2°CAssay Description:Assays were performed in white, flat-bottom, 384-well ProxiPlates (Perkin Elmer). The final assay volume was 10 μL prepared from additions of Hi...More data for this Ligand-Target Pair
